Merck (MRK) Gross Margin (2009 - 2026)
Merck (MRK) reported Gross Margin of 74.24% for Q1 2026, down 374.0% year-over-year from 27.1% in Q1 2025, and up 12.23% on a QoQ basis from 66.15% in Q4 2025.
Merck (MRK) has 18 years of Gross Margin data on file, last reported at 74.24% in Q1 2026.
- Quarterly Gross Margin fell 374.0% year-over-year to 74.24% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 73.91% (down 251.0% YoY) and the FY2025 annual result came in at 74.8%, down 152.0% from the prior year.
- Gross Margin advanced to 74.24% in Q1 2026 per MRK's latest filing, from 66.15% in the prior quarter.
- Across five years, Gross Margin topped out at 77.98% in Q1 2025 and bottomed at 66.15% in Q4 2025.
- The 5-year median for Gross Margin is 73.7% (2022), against an average of 73.79%.
- The widest annual swing landed in 2023, when Gross Margin soared 673 bps; it then tumbled 935 bps in 2025.
- Tracing MRK's Gross Margin over 5 years: stood at 71.94% in 2022, then climbed by 2 bps to 73.26% in 2023, then advanced by 3 bps to 75.5% in 2024, then declined by 12 bps to 66.15% in 2025, then gained by 12 bps to 74.24% in 2026.
- Per Business Quant, the three latest MRK Gross Margin figures stand at 74.24% (Q1 2026), 66.15% (Q4 2025), and 77.69% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 81.93% |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 66.31% |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 71.88% |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 74.24% |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 68.16% |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 79.24% |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | -51.69% |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 70.22% |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 74.24% |
| Dec 31, 2025 | 66.15% |
| Sep 30, 2025 | 77.69% |
| Jun 30, 2025 | 77.50% |
| Mar 31, 2025 | 77.98% |
| Dec 31, 2024 | 75.50% |
| Sep 30, 2024 | 75.51% |
| Jun 30, 2024 | 76.76% |
| Mar 31, 2024 | 77.56% |
| Dec 31, 2023 | 73.26% |
| Sep 30, 2023 | 73.29% |
| Jun 30, 2023 | 73.24% |
| Mar 31, 2023 | 72.90% |
| Dec 31, 2022 | 71.94% |
| Sep 30, 2022 | 73.70% |
| Jun 30, 2022 | 71.11% |
| Mar 31, 2022 | 66.17% |
| Dec 31, 2021 | 71.35% |
| Sep 30, 2021 | 73.77% |
| Jun 30, 2021 | 72.78% |
| Mar 31, 2021 | 69.90% |
| Dec 31, 2020 | 54.06% |
| Sep 30, 2020 | 72.43% |
| Jun 30, 2020 | 70.63% |
| Mar 31, 2020 | 72.53% |
| Dec 31, 2019 | 62.09% |
| Sep 30, 2019 | 67.81% |
| Jun 30, 2019 | 71.08% |
| Mar 31, 2019 | 71.78% |
| Dec 31, 2018 | 70.09% |
| Sep 30, 2018 | 66.47% |
| Jun 30, 2018 | 67.35% |
| Mar 31, 2018 | 68.28% |
| Dec 31, 2017 | 67.03% |
| Sep 30, 2017 | 67.97% |
| Jun 30, 2017 | 68.62% |
| Mar 31, 2017 | 67.68% |
| Dec 31, 2016 | 65.68% |
| Sep 30, 2016 | 67.64% |
| Jun 30, 2016 | 63.65% |
| Mar 31, 2016 | 61.64% |
| Dec 31, 2015 | 62.31% |
| Sep 30, 2015 | 62.66% |
| Jun 30, 2015 | 61.64% |
| Mar 31, 2015 | 62.13% |
| Dec 31, 2014 | 64.23% |
| Sep 30, 2014 | 60.00% |
| Jun 30, 2014 | 55.25% |
| Mar 31, 2014 | 61.97% |
| Dec 31, 2013 | 59.30% |
| Sep 30, 2013 | 62.80% |
| Jun 30, 2013 | 61.09% |
| Mar 31, 2013 | 62.90% |
| Dec 31, 2012 | 64.56% |
| Sep 30, 2012 | 63.99% |
| Jun 30, 2012 | 66.60% |
| Mar 31, 2012 | 65.59% |
| Dec 31, 2011 | 66.03% |
| Sep 30, 2011 | 63.80% |
| Jun 30, 2011 | 64.74% |
| Mar 31, 2011 | 64.95% |
| Dec 31, 2010 | 63.29% |
| Sep 30, 2010 | 62.33% |
| Jun 30, 2010 | 59.91% |
| Mar 31, 2010 | 54.33% |
| Dec 31, 2009 | 51.44% |
| Sep 30, 2009 | 76.36% |
| Jun 30, 2009 | 77.05% |
| Mar 31, 2009 | 75.23% |